Support for parents of children with congenital heart disease during surgery
Official title: Evaluation of the Feasibility of Support for the Management of Parental Stress in Surgical Resuscitation of Congenital Heart Diseases
Run by University Hospital, Bordeaux · NCT06884046 · Data updated 2026-11-12
This study is testing a new support program to see if it can help reduce stress for parents of babies with congenital heart disease during their surgery.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 0 Days to 28 Days |
| Sex | All |
| Enrollment | 40 (estimated) |
| Sponsor | University Hospital, Bordeaux Academic / other |
| Locations | 1 site (Pessac, France) |
| Status | Recruiting |
| Started | February 6, 2025 |
| Main results expected | February 6, 2027 |
| Study ends | February 6, 2027 |
| Registry record updated | March 19, 2025 |
| Trial ID | NCT06884046 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are parents of fetuses diagnosed with congenital heart disease who will undergo surgery within the first 28 days of life.
✕Probably not a fit
Parents who do not understand or read French or those with major psychiatric disorders may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates a personalized support model aimed at reducing parental stress during the neonatal surgical management of congenital heart disease. It focuses on providing comprehensive, multidisciplinary care starting from the antenatal period, addressing the unique challenges faced by families. The intervention includes consultations with a paramedical team and tailored support projects to meet the specific needs of parents. The effectiveness of this approach will be assessed through parental stress evaluations at various stages of the care journey.
Why it matters
Potential benefit: If successful, this approach could significantly improve the well-being of parents and enhance the neurodevelopmental outcomes for their children.
How similar studies have gone: While there is limited data on similar personalized support models, the approach is innovative and may provide new insights into managing parental stress in this context.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Parents whose fetus has congenital heart disease diagnosed in antenatal, which will be operated in the neonatal period (between 0 and 28 days of life) within our sector. * Parents followed in the congenital heart disease sector of the University Hospital of Bordeaux as soon as the diagnosis is announced in antenatal. * Free, informed and signed written consent of the couple or single mother in a single parent setting or by a third person (in case of physical disability of the participant) and the investigator (no later than the day of inclusion and before any examination required by the research). * Person affiliated or beneficiary of a social security scheme (excluding AME). * Parents with parental authority. Exclusion Criteria: * Parents who do not understand or read French and cannot be accompanied by a third party for translation. * Parents with major psychiatric disorders. * Parents deprived of liberty due to ongoing legal proceedings. * Parents under guardianship or curatorship or unable to personally express consent.
Where it's running
-
Hôpital Cardiologique Haut-Lévêque
Pessac, France, France Recruiting
Study contacts
- Study coordinator: Laurie PONTEINS
- Email: laurie.ponteins@chu-bordeaux.fr
- Phone: +33 05 57 65 67 93
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
12-week home heart rehabilitation program for children with complex congenital heart disease.
This program will test whether a 12-week remote cardiac rehabilitation program can improve heart and lung fitness and quality of life in children aged 8–18 with complex congenital heart disease.
-
Surgical techniques and outcomes across the lifespan in congenital heart disease in China
See which surgical factors and care patterns affect recovery after heart surgery for people with complex congenital heart disease in China.
-
Optimal timing and treatment strategies for newborn complex congenital heart disease surgery
This project will test whether doing heart surgery within the first week of life versus after day seven leads to fewer deaths and complications for newborns with complex congenital heart defects.
-
Evaluation of a heart valve for patients with pulmonary valve dysfunction
This study tests a new heart valve to see if it can safely help people with problems in their pulmonary valve or right ventricular outflow tract.
-
Adapting and testing PEN-Plus in Zambian primary care
Aiming to see if the PEN-Plus package can be adapted and used in two Zambian hospitals to better manage chronic diseases like heart disease, diabetes, hypertension, and sickle cell in primary care.
-
Wireless NIRS Sensor Use in the NICU for Monitoring on Neonates
A wireless NIRS sensor is tested on infants in the NICU to see how well it stays on and how it notes brain signals when used alongside standard wired sensors.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.